BlackRock Advisors’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.66M Sell
23,585
-12,437
-35% -$1.44M ﹤0.01% 1386
2016
Q3
$4.63M Sell
36,022
-147
-0.4% -$17.6K ﹤0.01% 1152
2016
Q2
$3.95M Buy
36,169
+10,051
+38% +$1M ﹤0.01% 1195
2016
Q1
$2.48M Buy
26,118
+1,265
+5% +$107K ﹤0.01% 1332
2015
Q4
$2.24M Sell
24,853
-1,017
-4% -$86.3K ﹤0.01% 1368
2015
Q3
$2.4M Sell
25,870
-917
-3% -$80.8K ﹤0.01% 1303
2015
Q2
$1.76M Buy
26,787
+1,930
+8% +$128K ﹤0.01% 1328
2015
Q1
$1.78M Buy
24,857
+3,671
+17% +$199K ﹤0.01% 1271
2014
Q4
$806K Sell
21,186
-1,045
-5% -$33K ﹤0.01% 1633
2014
Q3
$552K Sell
22,231
-477
-2% -$12.1K ﹤0.01% 1890
2014
Q2
$571K Sell
22,708
-3,094
-12% -$72K ﹤0.01% 1924
2014
Q1
$672K Buy
25,802
+1,334
+5% +$36.9K ﹤0.01% 1836
2013
Q4
$654K Buy
24,468
+1,519
+7% +$37.5K ﹤0.01% 1833
2013
Q3
$437K Buy
22,949
+201
+0.9% +$4.59K ﹤0.01% 2024
2013
Q2
$490K Buy
+22,748
New +$457K ﹤0.01% 1841

Other funds holding ABMD

BlackRock Advisors's ABMD Position: Q4 2016 in Review

BlackRock Advisors reduced its Abiomed Inc (ABMD) stake by 35% in Q4 2016, selling an estimated $1.44M and leaving 23,585 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

BlackRock Advisors first reported a position in ABMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.63M in Q3 2016. 297 funds tracked by Wall St. Rank hold ABMD as of Q4 2016.

  • BlackRock Advisors held 23,585 shares of Abiomed Inc worth $2.66M as of Q4 2016.
  • BlackRock Advisors sold 12,437 Abiomed Inc shares in Q4 2016, an estimated $1.44M.
  • Abiomed Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1386 holding.
  • BlackRock Advisors first reported a position in Abiomed Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Advisors's Abiomed Inc position peaked at $4.63M in Q3 2016.
  • 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.